![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 31, 24115-24123, August 4, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the University of Hohenheim, Institute of Physiology, D-70593
Stuttgart, Germany
Received for publication, March 6, 2000, and in revised form, May 3, 2000
Fast kinetics and sensitivity of olfactory
signaling raise the question of whether the participating proteins may
be associated in supramolecular transduction complexes. We found
evidence that caveolin proteins could play an important role in
organizing signaling elements in olfactory sensory neurons. Western
blot analysis indicated that caveolins are highly enriched in olfactory
sensory membranes, where they co-localize in detergent-insoluble
complexes with key components of the signaling pathways. Furthermore,
the results of immunoprecipitation experiments suggest that G proteins
and effector enzyme form preassembled subcellular complexes with
caveolins. Since anti-caveolin antibodies and synthetic peptides
derived from the scaffolding domains of caveolin-1 and caveolin-2
effectively attenuated second messenger responses in sensory cilia
preparations in a characteristic manner, the data led to the suggestion
that caveolins could mediate the assembly of signaling complexes within specialized membrane microdomains of olfactory sensory neurons.
In mammals, odorants bind to heptahelical receptors on specialized
sensory neurons, stimulating heterotrimeric G proteins associated with
the inner face of the plasma membrane. Consequently, effector enzymes
are activated, resulting in a fast and transient pulse of second
messengers, which finally trigger the electric response of the cell
(1-5). The chemosensory signal transduction process is highly
sensitive (6, 7) and extremely rapid (8). These findings fuel the
hypothesis that the participating molecules may be organized in
preassembled signaling complexes to minimize diffusion routes and to
control cross-talk between different signaling pathways (9).
Specialized membrane microdomains and scaffolding proteins have been
proposed as structural organizers for such multimolecular signaling
assemblies in various cell types (10-12).
There is accumulating evidence that caveolin proteins may be involved
in organizing signal transduction pathways at the plasma membrane
(13-17). Caveolins are 21-24-kDa membrane proteins, originally identified in trans-Golgi network-derived exocytotic vesicles (18) and
flask-shaped membrane invaginations called caveolae (19). Caveolins are
inserted into the lipid bilayer by an internal hydrophobic hairpin
domain, which was illustratively described as the caveolin "greasy
elbow configuration" (20). Caveolins strongly bind cholesterol (21)
and reportedly form high molecular weight oligomers (22, 23). Three
caveolin subtypes have been identified, with caveolin-1 (24) and
caveolin-2 (25) being ubiquitously expressed in many cell types,
whereas caveolin-3 was found to be muscle-specific (26, 27). It has
been proposed that caveolin-1 and caveolin-2 could function
cooperatively in the formation and stabilization of large lipid
microdomains (28).
Simons and Ikonen propose a "raft hypothesis" for the lateral
organization of lipid bilayers (12). Accordingly, assemblies of
sphingolipids and cholesterol create biochemically distinct microdomains (rafts) in a glycerophospholipid environment. Such rafts
may recruit and exclude specific sets of membrane proteins based on
their physicochemical properties and may therefore be viewed as
platforms to concentrate signaling molecules within the lipid bilayer.
The properties of caveolin could enable this protein to sequester raft
lipids, eventually forming and organizing large stabilized raft domains
in the plasma membrane (28, 29). In addition, caveolins reportedly
interact with multiple components of G protein-mediated signaling
pathways, including receptors, G proteins, and effector enzymes (14,
30-33). Accordingly, caveolin-mediated clustering and dispersion of
raft domains could contribute to regulating and shaping G
protein-mediated signaling.
In this study we addressed the question of whether caveolins may play
such a role in olfactory sensory neurons. We examined their subcellular
distribution in the main olfactory epithelium (MOE)1and vomeronasal organ
(VNO) of the rat and evaluated their possible function in the
odor-induced second messenger signaling.
Materials
Male and female adult Harlan Sprague-Dawley rats were purchased
from Charles River (Sulzfeld, Germany). The odorants citralva (3,7-dimethyl-2,6-octadiennitrile), hedione
(3-oxo-2-pentylcyclopentaneacetic acid methyl ester), eugenol
(2-methoxy-4-(2-propenyl)phenol), lilial
(para-butyl- Peptides
Peptides corresponding to the scaffolding domains of caveolin-1
(amino acid positions 82-101, DGIWKASFTTFTVTKYWFYR) and caveolin-2 (amino acid positions 54-73, DKVWICSHALFEISKYVMYK) were synthesized by
Dr. H. Kalbacher (University of Tübingen, Germany) and purified by high pressure liquid chromatography to >98%, as confirmed by mass
spectrometric analysis. A control peptide located N-terminal from the
scaffolding domain of caveolin-1 (amino acid positions 53-81,
RDPKHLNDDVVKIDFEDVIAEPEGTHSF) was purchased from Interactiva (Ulm, Germany).
Methods
Isolation of Sensory Cilia from Main Olfactory
Epithelia--
Olfactory cilia were prepared using the calcium shock
method according to Anholt (34). Briefly, after a short wash of the olfactory epithelia in ice-cold Ringer solution (120 mM
NaCl, 5 mM KCl, 1.6 mM
K2HPO3, 25 mM NaHCO3,
7.5 mM glucose, pH 7.4), the tissue was subjected to Ringer
solution supplemented with 10 mM calcium chloride and
gently stirred for 5 min at 4 °C. Detached cilia were isolated by
three sequential centrifugation steps for 5 min at 7,700 × g. The supernatants were collected, and the resulting pellets were resuspended in Ringer solution including 10 mM
calcium as described above. The cilia preparation was collected by a
final centrifugation step of the pooled supernatants for 15 min at
27,000 × g. The resulting pellet containing the cilia
was resuspended in hypotonic TME buffer (10 mM Tris, 3 mM MgCl2, 2 mM EGTA, pH 7. 4) and
stored at Isolation of Sensory Microvilli Fragments from Vomeronasal
Organs--
Microvilli fractions from rat VNO were prepared as
described previously (35). Briefly, VNOs were removed from fertile
female rats, washed twice in Ringer solution, and stored frozen in
liquid nitrogen until further use. VNOs from 30-60 animals were thawed on ice, minced, and subsequently stirred for 10 min at 4 °C in Ringer solution containing 10 mM calcium chloride. After
removing the debris by centrifugation (10 min, 3,000 × g), the supernatant was collected while the pellet was
resuspended in Ringer solution containing 10 mM calcium and
processed as described above. The pooled supernatants were centrifuged
for 30 min at 48,000 × g, and the resulting pellet
containing the microvilli membrane fragments was resuspended in
hypotonic TME buffer and stored in aliquots at Isolation of Triton X-100-insoluble Membrane
Domains--
Detergent-insoluble membrane fractions were purified as
described previously (37). Briefly, freshly dissected rat olfactory epithelia from the nasal septum and the ethmoid turbinates or from VNOs
were collected and minced in TME buffer. An aliquot of 1 ml of protein
solution (4 µg/µl) was diluted with lysis buffer (25 mM
Mes, 150 mM NaCl, 1 mM EGTA, 1 mM
phenylmethylsulfonyl fluoride, 10 µg/ml each of aprotinin, leupeptin,
and pepstatin, pH 6.5), adjusted to a final concentration of 1% (v/v)
Triton X-100 or, alternatively, 60 mM octyl glycoside, and
solubilized for 10 min on ice. Subsequently, samples were mixed with an
equal volume of 80% sucrose in lysis puffer, placed on the bottom of a
12-ml centrifuge tube, and overlaid with a discontinuous sucrose gradient (6 ml of 30% sucrose, 4 ml of 5% sucrose, both prepared in
lysis buffer). Samples were centrifuged at 200,000 × g
for 16 h. Fractions of 1 ml were collected from the top (fraction 1-12), whereas the pellet of the gradient was resuspended in 1 ml of
lysis buffer (fraction 13). Aliquots of each fraction were stored at
Immunoprecipitation--
Aliquots of detergent-insoluble
membrane fractions of olfactory epithelium or isolated olfactory cilia
isolated by equilibrium sucrose density centrifugation were lysed for
10 min on ice with immunoprecipitation buffer (50 mM Tris,
100 mM NaCl, 1 mM phenylmethylsulfonyl fluoride, 10 µg/ml of each aprotinin, leupeptin, pepstatin, pH 7.4)
containing 60 mM oytyl glycoside. The lysate was
centrifuged at 12,000 × g for 15 min, and the
supernatant was incubated overnight at 4 °C with an
agarose-conjugated anti-caveolin-1 antibody; after three washes, bound
protein was eluted with an aliquot of 5× sample buffer (625 mM Tris/HCl, pH 6.8, 50% glycerol, 5% SDS, 7.5 mM dithiothreitol, 0.05% bromphenol blue), boiled for 2 min, and subsequently subjected to SDS-PAGE and immunoblotting.
SDS-PAGE and Western Blot Analysis--
Aliquots of sucrose
gradient fractions or protein samples from sensory epithelia (38)
were mixed with 5× sample buffer, boiled for 2 min, and subjected to
SDS-polyacrylamide gel electrophoresis using the Laemmli buffer system
(39).
The separated proteins were transferred onto nitrocellulose membranes
using a semidry blotting system (Amersham Pharmacia Biotech). The blot
was stained with Ponceau S, dried, and stored at 4 °C until further
use. For Western blot analysis, nonspecific binding sites were blocked
with 5% nonfat milk powder (Naturaflor, Dietmannsriel, Germany) in 10 mM Tris/HCl, pH 8.0, 150 mM NaCl, and 0.05%
Tween 20 (TBST). Subsequently, the blots were incubated overnight at
4 °C with specific antibodies diluted in TBST containing 3% nonfat
milk powder. After three washes with TBST, a horseradish peroxidase-conjugated goat anti-rabbit IgG (1:10,000 dilution in TBST
with 3% milk powder) was applied. After three washes with TBST, the
ECL system was used to visualize bound antibodies.
Stimulation Experiments and Second Messenger
Determination--
Stimulation experiments were performed for 2 min at
37 °C in a shaking water bath as described previously (40). Briefly, test substances (e.g. odorants, forskolin, or GTP To analyze the expression of caveolins in rat olfactory
neurons, preparations of MOE and VNO were probed with
subtype-specific anti-caveolin antisera on Western blots. For
this purpose, total MOE and VNO samples were prepared by homogenizing
freshly dissected tissue in TME buffer. Sensory cilia and microvilli
fragments were separated from cells by the addition of calcium chloride
and purified by multiple centrifugation steps. Equal amounts of protein
from each preparation were subjected to SDS-PAGE and blotted onto
nitrocellulose membranes. The membranes were subsequently probed with
caveolin-1- and caveolin-2-specific antibodies, followed by
peroxidase-conjugated secondary antibodies and chemiluminescence detection.
As shown in Fig. 1, both antibodies
recognized a band of about 25 kDa in all preparations, consistent with
the predicted molecular masses of caveolin-1 and -2 of about
22.000 (30). Comparing the relative band intensities, we found both
caveolin subtypes enriched in cilia and microvilli fractions of MOE and
VNO, respectively. Centrifugation at high speed of cilia and microvilli
lead to a further enrichment of immunoreactivity of both caveolin
subtypes in the membrane pellet (data not shown). Antibodies directed
to the muscle-specific subtype caveolin-3 did not label a polypeptide at the predicted size of this caveolin subtype (data not
shown).
The data indicate that caveolin-1 and -2 are expressed in both
rat olfactory organs, MOE and VNO. Furthermore, enrichment of both
caveolin subtypes in sensory membranes points to a possible colocalization with components of olfactory signal transduction cascades in the appropriate subcellular compartments.
Caveolins have been found to segregate into detergent-insoluble
glycolipid-enriched membrane domains (DIGs) (31). To test whether this
may also be the case for caveolins expressed in olfactory tissues, we
isolated low density membrane fractions from MOE and VNO using sucrose
gradient ultracentrifugation. In the past, association with
detergent-insoluble cytoskeleton proteins was made responsible for
Triton X-100 insolubility at 4 °C. The detection of multiple glycosylphosphatidylinositol-anchored proteins in DIGs, however, established Triton X-100 insolubility as the basis for isolating lipid
rafts and associated proteins (44).
Olfactory epithelia from MOE and VNO were homogenized in Triton
X-100-containing lysis buffer at 4 °C, and after centrifugation, equal volumes of each of the 13 fractions were subjected to SDS-PAGE. Proteins were visualized by Coomassie Blue staining (Fig.
2A), revealing a highly skewed
protein distribution along the gradient. As determined by protein
quantification for each fraction (data not shown), more than 90% of
the total protein was found in high density fractions representing
Triton X-100-soluble components (lanes 9-13 in Fig.
2A). Only 10% of the total protein localized to the low
density fractions (lanes 1-8). In contrast, when the fractions were subjected to Western blot analysis as described above,
most of the caveolin-1 and -2 immunoreactivity was found concentrated
in low density fractions 3-5 of the MOE (Fig. 2, B and
C) and the VNO (Fig. 3,
A and B). Replacing Triton X-100 in the lysis
buffer by 60 mM octyl glycoside completely abolished this
pattern, leaving all caveolin-1 immunoreactivity from MOE (Fig.
2D) and from VNO (Fig. 3C) in the high density
fractions 10-13. Similar results were obtained for caveolin-2 (data
not shown). These results demonstrate that both caveolin subtypes show
a strong tendency to associate with DIGs isolated from olfactory epithelia as described for other tissues (45).
A Possible Role for Caveolin as a Signaling Organizer in
Olfactory Sensory Membranes*
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-methylhydrocinnamic aldehyde), and lyral (4-(4-hydroxy-4-methylpentyl)-3-cyclohexene-10-carboxyldehyde) were
provided by DROM (Baierbrunn, Germany). Isovaleric acid
(3-methylbutanoic acid), triethylamine, GTP
S, and goat anti-rabbit
IgG-conjugated horseradish peroxidase were purchased from Sigma.
Forskolin and 3-isobutyl-1-methylxanthine were supplied by Calbiochem.
Antibodies against G
s, G
i,
G
o, adenylyl cyclase type III, phospholipase C
2
(PLC
2), caveolin-1, caveolin-3, as well as agarose-conjugated caveolin-1 antibodies were provided by Santa Cruz Biotechnology (Santa Cruz, CA). Caveolin-2-specific antibodies were purchased from Affiniti (Mamhead, UK). The enhanced chemiluminescence system (ECL) for Western blots, the radioligand assay kits for cAMP, and
myo-inositol 1,4,5-trisphosphate (IP3)
determination were provided by Amersham Pharmacia Biotech. Unless
otherwise specified, all reagents were from Sigma and had the purity of
more than 99%.
70 °C.
70 °C. Protein
concentrations were measured by the Bradford method (36).
70 °C and subjected to SDS-PAGE.
S) were
diluted in reaction buffer (200 mM NaCl, 10 mM
EGTA, 50 mM Mops, 2.5 mM MgCl2, 1 mM dithiothreitol, 0.05% sodium cholate, 1 mM
ATP, 4 µM GTP, 12 nM free calcium calculated
and adjusted as described (41), pH 7.4). To prevent degradation of cAMP
and IP3, stimulation was performed in the presence of
either 1 mM 3-isobutyl-1-methylxanthine or 20 mM LiCl. The reaction was started by mixing 200 µl of
prewarmed reaction buffer with 30 µl of isolated olfactory cilia.
After stopping the reaction by the addition of 100 µl of ice-cold
perchloric acid (7%), quenched samples were stored on ice for 20 min,
followed by determination of the concentrations of cAMP or
IP3 according to Steiner et al. (42) and Palmer
et al. (43), respectively. The applied concentrations of
the different modulators in the results section represent
concentrations during pretreatment of the microvilli preparations or
ligand concentrations in the reaction buffer.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (14K):
[in a new window]
Fig. 1.
Subcellular distribution of caveolins in rat
olfactory sensory neurons. 25 µg of isolated olfactory cilia
(Ci) or whole olfactory epithelium (OE) of the
MOE (A) as well as microvilli fragments (Mv) and
total preparations of the VNO (S1) (B) were
subjected to SDS-PAGE (12.5% acrylamide), transferred to
nitrocellulose, and assayed for caveolin immunoreactivity with
subtype-specific antibodies to caveolin-1 and -2 (1:1,000 dilution).
Both antibodies labeled a band with a molecular mass of about 25 kDa.
The relative band intensities show both proteins enriched in cilia and
microvilli as compared with total protein. The molecular masses (kDa)
of standard proteins are indicated.

View larger version (30K):
[in a new window]
Fig. 2.
Subcellular fractionation of olfactory
sensory tissue from the MOE. Tissue from the MOE was homogenized
in either lysis buffer with 1% Triton X-100 (A-C) or 60 mM octyl glycoside (D) and fractionated by
discontinuous sucrose gradient centrifugation. Equal aliquots of each
fraction were subjected to SDS-PAGE, and the gels were stained with
Coomassie Blue (A). Fractions 1-8 represent the 5-30%
sucrose layers, fractions 9-12 represent the 40% sucrose layer, and
fraction 13 represents the insoluble pellet. Equivalent gels were
blotted on nitrocellulose membranes, where immunoreactivity of
caveolin-1 (B) and caveolin-2 (C) was visualized
with subtype-specific antibodies (1:1,000 dilution). The bulk of
caveolin immunoreactivity was found in fractions 3 and 4, which exclude
more than 90% of total cellular protein as determined by densitometric
analysis of the Coomassie gels. In contrast, solubilization with octyl
glycoside shifted caveolin-1 immunoreactivities to the low density
fractions 10-13 (D).

View larger version (14K):
[in a new window]
Fig. 3.
Subcellular fractionation of olfactory
sensory tissue from the VNO. Low density Triton X-100-insoluble
fractions were obtained from sensory tissue of the VNO using a sucrose
density gradient centrifugation procedure. Equal aliquots were
collected from the top of the gradient and subjected to SDS-PAGE. Upon
solubilization at 4 °C with Triton X-100, endogenous caveolin-1
(A) and caveolin-2 (B), visualized with
subtype-specific antibodies (1:1,000), are restricted to the low
density fractions 3 and 4, whereas upon treatment with octyl glycoside,
caveolin-1 is localized to the high density fractions 10-13
(C).
To test whether key components of the olfactory G protein-coupled
signal transduction cascades are enriched within DIG fractions from rat
olfactory tissues along with caveolins, we monitored the distribution
of two major olfactory G
subtypes from MOE, G
s and
G
o (46) in sucrose density gradients. Western blot analysis with subtype-specific anti-G
antibodies detected some immunoreactivity for G
s (Fig.
4A) and G
o
(Fig. 4B) in Triton X-100-soluble high density fractions
7-12. The most of these proteins, however, were concentrated in Triton
X-100-insoluble low density fractions 4-6. Replacing Triton X-100
by 60 mM octyl glycoside in the lysis buffer released the
immunoreactivity for both proteins (data shown for G
s
only) into the soluble high density fractions (Fig. 4C).
|
Similar results were obtained when preparations from VNO were used
(Fig. 5). G
i and
G
o subtypes have been suggested to mediate chemosensory
signal transduction in this tissue (47-49). Again, the majority of
both G protein
-subunits co-migrated with the Triton X-100-insoluble
low density fractions. Comparable experiments with an antibody against
a conserved domain of all five known rat G
subtypes revealed a
similar distribution (data not shown).
|
To test whether further downstream signaling molecules of the olfactory
transduction pathways co-migrate in the low density fractions along
with caveolins and G proteins, the distributions of two key effector
enzymes, adenylyl cyclase III and PLC
2 (50, 51), were monitored in
sucrose density gradients. Again, homogenates from MOE were prepared as
described above and subjected to sucrose gradient centrifugation. After
SDS-PAGE separation of each fraction, the proteins were blotted onto
nitrocellulose membranes and probed with antibodies specific to rat
adenylyl cyclase III (Fig. 6A) and PLC
2 (Fig. 6B) proteins. We found significant
immunoreactivity for both enzymes in Triton X-100-insoluble low density
fractions 4-6, suggesting their co-localization with caveolins and G
proteins in common lipid compartments of sensory membranes.
|
Several studies indicate that in vivo, caveolin 1 and
caveolin 2 form a hetero-oligomeric complex (for review, see Ref. 16). To explore whether caveolin-1 may interact with caveolin-2,
co-immunoprecipitation experiments were performed using a
caveolin-1-specific antibody conjugated to agarose; therefore, Triton
X-100-insoluble low density membrane fractions isolated by sucrose
density centrifugation were solubilized with octyl glycoside and
subsequently used in immunoprecipitation experiments; to assess the
specificity of the procedure, protein samples were incubated either
with non-immune rabbit IgG (Fig. 7, IgG), or
alternatively, antibodies used in Western blotting were preincubated
with the specific peptide (Fig. 7, +P). As demonstrated in
Fig. 7, caveolin-1 was effectively precipitated by its respective antibody (panel A,
Cav1) compared with the labeling of the caveolin-1 antibody
observed in isolated olfactory cilia (panel A,
Ci), whereas no immunostaining was detectable in control
samples (panel A, IgG and Cav1 + P).
When caveolin-1 precipitates were probed with caveolin-2-specific
antibodies, an intense immunoreactivity for caveolin-2 was observed
(Fig. 7, panel B, Cav2), indicating that
hetero-oligomeric complexes of caveolin-1 and caveolin-2 exist in the
olfactory sensory epithelium.
|
Caveolin forms higher ordered complexes with a variety of signal
transduction molecules (for review: see Ref. 16); to determine if
caveolin-1 is associated with olfactory G protein
-subunits, caveolin-1 precipitates were probed with subtype-specific antibodies for G
s and G
o; as demonstrated in Fig. 7,
no staining for both G protein-subtypes was detected in control
samples, whereas in the caveolin precipitates, a significant amount
of G
s (panel C) and G
o
(panel D) was detected. To explore whether effector enzymes
involved in olfactory signaling are also associated with caveolin,
immunoprecipitates of caveolin-1 antibodies were also assessed for
adenylyl cyclase and PLC
2 immunoreactivity; Fig. 7 shows that
adenylyl cyclase (panel E) and PLC
2 (panel
F) are both co-eluted with caveolin-1, indicating that G protein
-subunits as well as effector enzymes of the olfactory signaling
pathways form complexes with caveolin-1.
To examine the functional significance of interactions between
caveolins and other olfactory signaling molecules we performed two
different experimental approaches. Using antibodies specific to
caveolin-1 (Fig. 8A) and
caveolin-2 (Fig. 8B), we attempted to sterically protect
caveolin proteins from homo- and heterophilic interactions. In
addition, we sought to competitively replace caveolins from potential
interaction partners with synthetic peptides corresponding to the amino
acid sequence of caveolin-1 (Fig.
9A) and caveolin-2 (Fig.
9B) scaffolding domains, which reportedly are involved in
homo- and hetero-oligomerization of caveolins and in binding to
other signaling proteins (20, 23, 52, 53).
|
|
Samples of cilia preparations were preincubated with different
dilutions of antibodies specific to caveolin-1 or caveolin-2 and
subsequently stimulated with a mixture of odorants inducing cAMP
responses (citralva, hedione, eugenol; 10 µM each) (40) or odorant components eliciting IP3 formation (lilial,
lyral, ethylvanillin; 10 µM each) (54). Alternatively,
downstream signaling elements were activated directly with GTP
S for
G proteins and forskolin for adenylyl cyclase. The reaction was stopped
by the addition of perchloric acid, and second messenger responses were quantified. Both anti-caveolin-1 (Fig. 8A) and
anti-caveolin-2 (Fig. 8B) antibodies effectively inhibited
cAMP formation in a concentration-dependent manner.
Notably, when stimulating downstream elements of the signaling cascade
directly, similar effects were observed, but the effectiveness of both
antibodies was gradually reduced the further downstream the stimuli
acted. The antibodies (1:1000 dilution) elicited a reduction to ~30%
of the control cAMP response when stimulating with odorants. In
contrast, when stimulating G proteins with GTP
S, a reduction to
~50% of the control level was observed for both antibodies. Finally,
when adenylyl cyclase III was directly activated by forskolin, the observed level of cAMP was reduced to ~60% of control values. A
similar pattern was observed for IP3-mediated signaling
(data not shown), although direct stimulation of phospholipase C was not possible because no selective agonist for this enzyme is available.
Preincubation of cilia with synthetic peptides representing the
caveolin-1 (Fig. 9A) and caveolin-2 (Fig. 9B)
scaffolding domains instead of the antibodies induced comparable
effects. Concentrations of 10 µM caveolin-1 scaffolding
domain peptide reduced the odor-induced raise in second messenger
production to 17% for cAMP and to less than 10% for IP3
(data not shown). Experiments with caveolin-2 scaffolding domain
peptides led to similar results. Preincubation with a control peptide
unrelated to the scaffolding domain showed no effect on either cAMP
(Fig. 9C) or IP3 (not shown) signaling. As
observed for the antibody experiments, the reduction of odorant-induced
cAMP production was most pronounced. Both peptides evoked gradually
smaller effects when the second messenger response was induced by
GTP
S (30-40% of control values) or forskolin (45-65% of control values).
| |
DISCUSSION |
|---|
|
|
|---|
The results of this study suggest that caveolins may play an important role in olfactory signaling by assembling elements of the transduction machinery in microdomains of the chemosensory membranes. Immunoreactivity for caveolin-1 and caveolin-2 was found to be enriched in membrane protein fractions from cilia and microvilli preparations, the specialized chemosensory compartments of olfactory neurons in main olfactory epithelia and vomeronasal organs, respectively. Furthermore, caveolin-1 and caveolin-2 co-migrated in low buoyant density fractions along with several key components of the olfactory signal transduction cascades, including G proteins, adenylyl cyclase III, and phospholipase C. This indicates a possible co-localization of these molecules in situ in detergent-insoluble membrane domains, such as rafts or caveolae. Co-immunoprecipitation experiments further support the idea of a possible molecular association of caveolins with key olfactory signaling molecules. Most importantly, antibodies to both caveolins as well as synthetic peptides representing the scaffolding domain effectively suppressed the odor-induced second messenger formation.
It has been suggested that caveolins may act as scaffolding proteins to organize preassembled signaling complexes at the plasma membrane (30, 16), but models for molecular mechanisms underlying this function remain incomplete. Simons and co-workers (29, 55) recently proposed that caveolin-1 might stabilize lipid raft microdomains. Small and highly dynamic lipid domains that are rich in cholesterol and sphingolipids are thought to form spontaneously in biological membranes based on the differential miscibility of lipids (12, 29, 56-58). Caveolins may stabilize these domains, since they bind cholesterol (21) and oligomerize to form large assemblies of up to 600 kDa (23). Cooperatively, caveolin-1 and caveolin-2 may therefore induce the formation of large lipid domain clusters, regulating their size by intermolecular cross-linking. This possibility is particularly attractive because the oligomerizing property of caveolin-2 may be modified by phosphorylation through protein kinases (55), thus offering a potential cue for physiological regulation.
In this context, our observations are consistent with the notion that in chemosensory membranes caveolins may contribute to assemble the olfactory signal transduction machinery in microdomains, thereby shaping and regulating the odor-induced second messenger responses. Antibodies to both caveolins effectively attenuated the odor-induced second messenger formation (Fig. 8). This inhibitory effect could result from steric or competitive hindrance of a direct interaction between caveolins and other signaling molecules. The same may hold true for the attenuating effect of synthetic peptides, representing the caveolin scaffolding domains (Fig. 9). The observation that scaffolding domains in fact interact with G proteins (52) and other signaling molecules (53, 59-63) is supportive to this idea. However, it was found that putative interaction partners bind differentially to each of the caveolins (53). Furthermore, scaffolding peptides from the two caveolins elicited different effects on G protein function and adenylyl cyclase III activity (25, 64). In the view of these findings it is somewhat surprising that peptides representing the scaffolding domains of caveolin-1 and caveolin-2 equally affected the olfactory signal transduction cascades.
A solution for this controversy may be provided by a slightly different
consideration. The scaffolding domain peptides, irrespective of whether
they represent caveolin-1 or caveolin-2, as well as antibodies to both
proteins could disturb the homo- and heterophilic interactions between
caveolin proteins themselves, a view that is consistent with the role
of the scaffolding domain in caveolin oligomerization (20, 23, 65).
This could trigger the dispersion of large stable lipid domain clusters
into small, dynamic microdomains, releasing the different signaling
molecules into a much larger diffusion territory and, consequently,
reducing the transduction efficiency. This notion is consistent with
the finding that all used antibodies and peptides attenuate second
messenger formation equally effectively and that scaffolding
domain-derived peptides only partially affected co-precipitation of
olfactory G proteins and effector enzymes (data not shown).
Furthermore, it would provide a possible explanation for the
observation that the inhibitory effect was more pronounced when second
messenger formation was induced via odorant receptors as compared with
responses induced by direct activation of G proteins and adenylyl
cyclase III. It seems an intriguing question, whether caveolin-mediated
coalescence and dispersion of lipid domains could play a role in
regulating the olfactory signal transduction processes or G
protein-coupled signaling cascades in general.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Kerstin Bach for excellent technical assistance and Jacques Payson for helpful discussion and critical reading of the manuscript.
| |
FOOTNOTES |
|---|
* This work was supported by the Deutsche Forschungsgemeinschaft, the Human Frontier Science Program, European Community Project ERBBIO 4 CT 960593, and the Fond der Chemischen Industrie.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
A recipient of the Margarethe von Wrangell Habilitations
stipendium from the Land Baden-Württemberg. To whom
correspondence should be addressed: University of Hohenheim, Inst. of
Physiology (230), Garbenstrasse 30, 70593 Stuttgart, Germany. Tel.:
49-711-459-2267; Fax: 49-711-459-3726; E-mail:
boekhoff@uni-hohenheim.de.
Published, JBC Papers in Press, May 17, 2000, DOI 10.1074/jbc.M001876200
| |
ABBREVIATIONS |
|---|
The abbreviations used are:
MOE, main olfactory
epithelium;
VNO, vomeronasal organ;
GTP
S, guanosine
5'-O-(3-thiotriphosphate);
PLC
2, phospholipase C
2;
IP3, myo-inositol 1,4,5-trisphosphate;
Mes, 4-morpholineethanesulfonic acid;
Mops, 4-morpholinepropanesulfonic
acid;
PAGE, polyacrylamide gel electrophoresis;
TBST, Tris-buffered
saline-Tween;
DIG, detergent-insoluble glycolipid-enriched membrane
domains.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Ache, B. W. (1994) Cell Biol. 5, 55-63 |
| 2. | Breer, H. (1994) Semin. Cell Biol. 5, 25-32 |
| 3. | Reed, R. R. (1994) Semin. Cell Biol. 5, 33-38 |
| 4. | Morales, B., and Bacigalupo, J. (1996) Biol. Res. 29, 333-341 |
| 5. | Schild, D., and Restrepo, D. (1998) Physiol. Rev. 2, 429-466 |
| 6. | Reed, R. R. (1992) Cold Spring Harbor Symp. Quant. Biol. 57, 501-504 |
| 7. | Firestein, S. (1996) Curr. Biol. 6, 666-667 |
| 8. | Breer, H., Boekhoff, I., and Tareilus, T. (1990) Nature 345, 65-68 |
| 9. | Neubig, R. R. (1994) FASEB J. 8, 939-946 |
| 10. | Anderson, R. G. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 10909-10913 |
| 11. | Sargiacomo, M., Sudol, M., Tang, Z.-L., and Lisanti, M. P. (1993) J. Cell Biol. 122, 789-807 |
| 12. | Simons, K., and Ikonen, E. (1997) Nature 387, 569-572 |
| 13. | Harder, T., and Simons, K. (1997) Curr. Opin. Cell Biol. 9, 534-542 |
| 14. | Kurzchalia, T. V., and Parton, R. G. (1999) Curr. Opin. Cell Biol. 11, 424-431 |
| 15. | Anderson, R. G. (1998) Annu. Rev. Biochem. 67, 199-225 |
| 16. | Okamoto, T., Schlegel, A., Scherer, P. E., and Lisanti, M. P. (1998) J. Biol. Chem. 273, 5419-5422 |
| 17. | Roy, S., Luetterforst, R., Harding, A., Apolloni, A., Etheridge, M., Stang, E., Rolls, B., Hanock, J. F., and Parton, R. G. (1999) Nat. Cell Biol. 1, 98-105 |
| 18. | Kurzchalia, T. V., Dupree, P., Parton, R. G., Kellner, R., Virta, H., Lehnert, M., and Simons, K. (1992) J. Cell Biol. 118, 1003-1014 |
| 19. | Rothberg, K. G., Heuser, J. E., Donzell, W. C., Ying, Y.-S., Glenney, J. R., and Anderson, R. G. W. (1992) Cell 68, 673-682 |
| 20. | Das, K., Lewis, R. Y., Scherer, P. E., and Lisanti, M. P. (1999) J. Biol. Chem. 274, 18721-18728 |
| 21. | Murata, M., Peränen, J., Schreiner, R., Wieland, F., Kurzchalia, T. V., and Simon, K. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 10339-10343 |
| 22. | Monier, S., Parton, R. G., Vogel, F., Behlke, J., Henske, A., and Kurzchalia, T. V. (1995) Mol. Biol. Cell 6, 911-927 |
| 23. | Sargiacomo, M., Scherer, P. E., Tang, Z.-L., Kubler, E., Song, K. S., Sanders, M. C., and Lisanti, M. P. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 9407-9411 |
| 24. | Glenney, J. R., and Soppet, D. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 10517-10521 |
| 25. | Scherer, P. E., Okamoto, T., Chun, M., Nishimoto, I., Lodish, H. F., and Lisanti, M. P. (1996) Proc. Natl. Acad. U. S. A. 93, 131-135 |
| 26. | Way, M., and Parton, R. G. (1995) FEBS Lett. 376, 108-112 |
| 27. | Tang, Z.-L., Scherer, P. E., Okamoto, T., Song, K., Chu, C., Kohtz, D. S., Nishimoto, I., Lodish, H. F., and Lisanti, M. P. (1996) J. Biol. Chem. 271, 2255-2261 |
| 28. | Harder, T., Scheiffele, P., Verkade, P. V., and Simons, K. (1998) J. Cell Biol. 141, 929-949 |
| 29. | Rietveld, A., and Simons, K. (1998) Biochim. Biophys. Acta 3, 467-479 |
| 30. | Lisanti, M. P., Scherer, P. E., Tang, Z., and Sargiacomo, M. (1994) Trends Cell Biol. 4, 231-238 |
| 31. | Parton, R. G., and Simon, K. (1995) Science 269, 1398-1399 |
| 32. | Schlegel, A., Volante, D., Engelman, J. A., Galbiati, F., Mehta, P., Zhang, X. L., Scherer, P. E., and Lisanti, M. P. (1998) Cell. Signal. 10, 457-463 |
| 33. | Shaul, P. W., and Anderson, R. G. W. (1998) Am. J. Physiol. 275, L843-L851 |
| 34. | Anholt, R. R., Aebi, U., and Snyder, S. H. (1986) J. Neurosci. 6, 1962-1969 |
| 35. | Kroner, C., Breer, H., Singer, A. G., and O'Connell, R. J. (1996) Neuroreport 25, 2989-2992 |
| 36. | Bradford, M. M. (1976) Anal. Biochem. 65, 248-254 |
| 37. | Song, K. S., Li, S., Okamoto, T., Quilliam, L. A., Sargiacomo, M., and Lisanti, M. P. (1996) J. Biol. Chem. 271, 9690-9697 |
| 38. | Krieger, J., Schleicher, S., Strotmann, J., Wanner, I., Boekhoff, I., Raming, K., De Geus, P., and Breer, H. (1994) Eur. J. Biochem. 219, 829-834 |
| 39. | Laemmli, U. K. (1970) Nature 225, 680-685 |
| 40. | Boekhoff, I., Touhara, K., Danner, S., Inglese, J., Lohse, M. J., Breer, H., and Lefkowitz, R. J. (1997) J. Biol. Chem. 272, 4606-4612 |
| 41. | Pershadsingh, H. A., and McDonald, J. M. (1979) J. Biol. Chem. 225, 4087-4093 |
| 42. | Steiner, A. L., Pagliara, A. S., Chase, L. R., and Kipnis, D. M. (1972) J. Biol. Chem. 247, 1114-1120 |
| 43. | Palmer, S., Hughes, K. T., Lee, D. Y., and Wakema, M. J. O. (1989) Cell. Signal. 1, 147-156 |
| 44. | Brown, D. A., and Rose, J. K. (1992) Cell 68, 533-544 |
| 45. | Lisanti, M. P., Tang, Z., Scherer, P. E., Kubler, E., Koleske, A. J., and Sargiacomo, M. (1995) Mol. Memb. Biol. 12, 121-124 |
| 46. | Schandar, M., Laugwitz, K.-L., Boekhoff, I., Kroner, C., Gudermann, T., Schultz, G., and Breer, H. (1998) J. Biol. Chem. 273, 16669-16677 |
| 47. | Halpern, M., Shapiro, L. S., and Jia, C. (1995) Brain Res. 677, 157-161 |
| 48. | Berghard, A., and Buck, L. B. (1996) J. Neurosci. 16, 908-918 |
| 49. | Krieger, J., Schmitt, A., Löbel, D., Gudermann, T., Schultz, G., Breer, H., and Boekhoff, I. (1999) J. Biol. Chem. 274, 4655-4662 |
| 50. | Bakalyar, H. A., and Reed, R. R. (1990) Science 250, 1403-1406 |
| 51. | Noé, J., and Breer, H. (1998) J. Neurochem. 71, 2286-2293 |
| 52. | Li, S., Okamoto, T., Chun, M., Sargiacomo, M., Casanova, J. E., Hansen, S. H., Nishimoto, I., and Lisanti, M. P. (1995) J. Biol. Chem. 270, 15693-15701 |
| 53. | Couet, J., Li, S., Okamoto, T., Ikezu, T., and Lisanti, M. P. (1997) J. Biol. Chem. 272, 6525-6533 |
| 54. | Breer, H., and Boekhoff, I. (1991) Chem. Senses 16, 19-29 |
| 55. | Scheiffele, P., Verkade, P., Fra, A. M., Virta, H., Simons, K., and Ikonen, E. (1998) J. Cell Biol. 140, 795-806 |
| 56. | Ahmed, S. N., Brown, D. A., and London, E. (1997) Biochemistry 36, 10944-10953 |
| 57. | Brown, D. A., and London, E. (1998) J. Memb. Biol. 164, 103-114 |
| 58. | Hooper, N. M. (1999) Mol. Memb. Biol. 16, 145-156 |
| 59. | Li, S., Couet, J., and Lisanti, M. P. (1996) J. Biol. Chem. 271, 29182-29190 |
| 60. | Oka, N., Yamamoto, M., Schwencke, C., Kawabe, J., Ebina, T., Ohno, S., Couet, J., Lisanti, M. P., and Ishikawa, Y. (1997) J. Biol. Chem. 272, 33416-33421 |
| 61. | Michel, J. B., Feron, O., Sacks, D., and Michel, T. (1997) J. Biol. Chem. 272, 15583-15586 |
| 62. | Carman, C. V., Lisanti, M. P., and Benovic, J. L. (1999) J. Biol. Chem. 274, 8858-8864 |
| 63. | Razani, B., Rubin, C. S., and Lisanti, M. P. (1999) J. Biol. Chem. 274, 26353-26360 |
| 64. | Toya, Y., Schwencke, C., Couet, J., Lisanti, M. P., and Ishikawa, Y. (1998) Endocrinology 139, 2025-2031 |
| 65. | Song, K. S., Tang, Z., Li, S., and Lisanti, M. P. (1997) J. Biol. Chem. 272, 4398-4403 |
This article has been cited by other articles:
![]() |
S. J. Kleene The Electrochemical Basis of Odor Transduction in Vertebrate Olfactory Cilia Chem Senses, November 1, 2008; 33(9): 839 - 859. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Levin, J. G. Coroneus, M. J. Cocco, and G. A. Weiss Exploring the interaction between the protein kinase A catalytic subunit and caveolin-1 scaffolding domain with shotgun scanning, oligomer complementation, NMR, and docking Protein Sci., March 1, 2006; 15(3): 478 - 486. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Brady, T. C. Rich, X. Le, K. Stafford, C. J. Fowler, L. Lynch, J. W. Karpen, R. L. Brown, and J. R. Martens Functional Role of Lipid Raft Microdomains in Cyclic Nucleotide-Gated Channel Activation Mol. Pharmacol., March 1, 2004; 65(3): 503 - 511. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Reisert, P. J. Bauer, K.-W. Yau, and S. Frings The Ca-activated Cl Channel and its Control in Rat Olfactory Receptor Neurons J. Gen. Physiol., August 25, 2003; 122(3): 349 - 364. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Liu, M. Rudick, and R. G. W. Anderson Multiple Functions of Caveolin-1 J. Biol. Chem., October 25, 2002; 277(44): 41295 - 41298. [Full Text] [PDF] |
||||
![]() |
C. Spilker, T. Dresbach, and K.-H. Braunewell Reversible Translocation and Activity-Dependent Localization of the Calcium-Myristoyl Switch Protein VILIP-1 to Different Membrane Compartments in Living Hippocampal Neurons J. Neurosci., September 1, 2002; 22(17): 7331 - 7339. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kobayakawa, R. Hayashi, K. Morita, K. Miyamichi, Y. Oka, A. Tsuboi, and H. Sakano Stomatin-Related Olfactory Protein, SRO, Specifically Expressed in the Murine Olfactory Sensory Neurons J. Neurosci., July 15, 2002; 22(14): 5931 - 5937. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-Y. Liou, W.-G. Deng, D. W. Gilroy, S.-K. Shyue, and K. K. Wu Colocalization and Interaction of Cyclooxygenase-2 with Caveolin-1 in Human Fibroblasts J. Biol. Chem., September 7, 2001; 276(37): 34975 - 34982. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||